Article in Molecular biology and evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Qihang ChenGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases & the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511436, China.ORCID 0000-0002-3166-7591
Senmao LiDepartment of Gastrointestinal Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510288, PR China.ORCID 0000-0003-0377-8566
Xianrui WuDepartment of Gastrointestinal Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510288, PR China.ORCID 0000-0002-4743-7133
Qing XuGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases & the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511436, China.ORCID 0009-0001-0047-480X
Ranran ZhuGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases & the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511436, China.ORCID 0009-0007-6103-5791
Yongsen RuanState Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.ORCID 0000-0002-5573-4154
Ao LanState Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.ORCID 0009-0003-3996-3031
Zihan LiuGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases & the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511436, China.ORCID 0009-0008-7633-9496
Jiarui WengGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases & the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511436, China.ORCID 0009-0003-4402-2279
Yanjiang ZhaoDepartment of Gastroenterology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China.ORCID 0009-0001-3304-2392
Xiying XuGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases & the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511436, China.ORCID 0009-0007-8060-6377
Xinyue QiGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases & the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511436, China.ORCID 0009-0009-1967-3938
Jinhong LaiGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases & the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511436, China.ORCID 0009-0009-8883-7318
Leyi XiaoGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases & the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511436, China.ORCID 0009-0004-1034-2685
Ping LanDepartment of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, PR China.ORCID 0000-0001-5206-5533
Chung-I WuState Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.ORCID 0000-0001-7263-4238
Bingjie ChenGMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases & the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 511436, China.ORCID 0000-0001-7689-2146
Funding
National Natural Science Foundation of China 32293193National Natural Science Foundation of China 32300492Talent Project of Guangzhou Medical University High-level University Construction 06-445-1094
6 · The paper itself
Abstract
The process of migration and colonization is important in evolution; for example, modern humans experienced multiple waves of migrations out of Africa. However, no data cover the spatio-temporal patterns sufficiently to be truly informative. Metastatic cancer provides a unique in vivo model to study these processes through rapid somatic evolution. Here, we apply the high-resolution sampling technique (Dense 3D Crypt-scale Sampling) to analyze hundreds of spatially mapped micro-samples from the primary colorectal cancer and liver metastases in two representative cases. This would be analogous to recording the "out-of-Africa" events in two repeats. Our results support that liver metastases arise from polyphyletic and polyclonal seeding events where multiple, genetically distinct clones colonize a new site together. Following colonization, these multi-clonal populations can evolve into distinct spatial architectures: segregated territories formed by cells with low motility, or highly intermixed patterns driven by high motility. The colonization (or seeding) process begins within the first third of the primary tumor's progression, creating a large number of widespread but clinically undetectable micrometastatic colonies. These findings support a model where metastatic competence is not an intrinsic trait of a single "winner" clone but an emergent property of multiple concurrent clones. Collectively, our work supports metastasis as a multi-stage process initiated early in tumor development, characterized by continuous polyclonal dissemination and the formation of spatially distinct clonal architectures. This general pattern may echo the ecology of migration and colonization in organismal evolution.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Full spatio-temporal analyses of migration and colonization in evolution-dense 3D mapping of cancer metastases provides new insights. · full record | OpenQuestion